APPLICATION
ANDA203991
TYPE
ANDA
ORIGINAL APPROVAL
2015-02-20
LATEST ACTION
2022-11-02
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued
Products
BIMATOPROSTDiscontinued
BIMATOPROST 0.03% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2022-11-02Labeling · Supplement 11 · standardAP
2022-11-02Labeling · Supplement 14 · standardAP
2022-11-02Labeling · Supplement 6 · standardAP
2020-11-24Manufacturing (CMC) · Supplement 9 · standardAP
2015-02-20UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.